Cargando…
Effect of Initial Aflibercept, Laser, or Observation on Low-Contrast Visual Acuity in Eyes With Diabetic Macular Edema and Good Vision: Ancillary Study Within a Randomized Clinical Trial
PURPOSE: To describe 2.5% low-contrast visual acuity (VA) among eyes with good vision despite center-involved diabetic macular edema and compare changes after initial management with aflibercept, laser, or observation. METHODS: This was an ancillary study within a multicenter randomized clinical tri...
Autores principales: | Beaulieu, Wesley T., Glassman, Adam R., Baker, Carl W., Maguire, Maureen G., Johnson, Chris A., Melia, Michele, Sun, Jennifer K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Association for Research in Vision and Ophthalmology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7937990/ https://www.ncbi.nlm.nih.gov/pubmed/34003937 http://dx.doi.org/10.1167/tvst.10.3.3 |
Ejemplares similares
-
Contrast Sensitivity Changes in Center Involving Diabetic Macular Edema Treated with Aflibercept
por: Nixon, Donald R, et al.
Publicado: (2021) -
The role of aflibercept in the management of diabetic macular edema
por: Chang, Andrew A, et al.
Publicado: (2015) -
The clinical utility of aflibercept for diabetic macular edema
por: Stewart, Michael W
Publicado: (2015) -
Benefits of aflibercept treatment for age-related macular degeneration patients with good best-corrected visual acuity at baseline
por: Minami, Sakiko, et al.
Publicado: (2018) -
Five-Year Outcome of Aflibercept Monotherapy for Exudative Age-Related Macular Degeneration with Good Baseline Visual Acuity
por: Kikushima, Wataru, et al.
Publicado: (2021)